Showing results (21-30 of 37) with videos related to
Sort By:
Pageof 4
Human Gene Therapy|February 11, 2005
Intratumoral administration of a recombinant canarypox virus expressing interleukin 12 in patients with metastatic melanomaPierre L Triozzi, Theresa V Strong, R Pat Bucy, et al.Journal of Surgical Oncology|July 3, 2019
Correlates of response and outcomes with talimogene laherperpvecAlice Y Zhou, Daniel Y Wang, Svetlana McKee, et al.Journal of Cutaneous Pathology|September 24, 2017
Chronic granulomatous dermatitis induced by talimogene laherparepvec therapy of melanoma metastasesAshlyn S Everett, Peter G Pavlidakey, Carlo M Contreras, et al.Journal for Immunotherapy of Cancer|November 22, 2017
Smoldering myocarditis following immune checkpoint blockadeTimothy G Norwood, Brian C Westbrook, Douglas B Johnson, et al.Advances in Radiation Oncology|July 26, 2017
A phase 2 study of radiosurgery and temozolomide for patients with 1 to 4 brain metastasesJohn B Fiveash, Waleed O Arafat, George E Naoum, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2018
E3611-A Randomized Phase II Study of Ipilimumab at 3 or 10 mg/kg Alone or in Combination with High-Dose Interferon-α2b in Advanced MelanomaAhmad A Tarhini, Sandra J Lee, Xiaoxue Li, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2008
Combination chemotherapy and ALVAC-CEA/B7.1 vaccine in patients with metastatic colorectal cancerHoward L Kaufman, Heinz-Josef Lenz, John Marshall, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2021
Phase 1 Trial of ALRN-6924, a Dual Inhibitor of MDMX and MDM2, in Patients with Solid Tumors and Lymphomas Bearing Wild-type TP53Mansoor N Saleh, Manish R Patel, Todd M Bauer, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2025
Phase 2, Open-Label, Multicenter Study of Nelitolimod in Combination with Pembrolizumab in Anti-PD-1 Treatment-Naive Advanced MelanomaAntoni Ribas, Mohammed M Milhem, Christopher J Hoimes, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 31, 2017
Phase III Randomized Study of 4 Weeks of High-Dose Interferon-α-2b in Stage T2bNO, T3a-bNO, T4a-bNO, and T1-4N1a-2a (microscopic) Melanoma: A Trial of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group (E1697)Sanjiv S Agarwala, Sandra J Lee, Waiki Yip, et al.Pageof 4